Video

The Changing Landscape of VTE Treatment

Publish date: May 21, 2014
Author(s):
Bauer K
Author and Disclosure Information

Watch as Kenneth A. Bauer, MD, discusses the new venous thromboembolism (VTE) oral agents and their impact on the future of care for patients with cancer.

 

For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations

Recommended Reading

Epoprostenol's Effect on Acute Pulmonary Embolism
Federal Practitioner
Silent Pulmonary Embolism: Measuring the Real Risk
Federal Practitioner
Higher Risk of Venous Thromboembolism with Bevacizumab
Federal Practitioner
A Leg Up on Deep Vein Thrombosis
Federal Practitioner
Low Molecular Weight Heparin for Pulmonary Embolism
Federal Practitioner
The Missed Pulmonary Embolism
Federal Practitioner
Prevention of Venous Thromboembolism After Total Joint Replacement: Rivaroxaban Update
Federal Practitioner

Related Articles